-
Product Insights
Limbal Stem Cell Deficiency (LSCD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Limbal Stem Cell Deficiency (LSCD) - Drugs In Development, 2023’, provides an overview of the Limbal Stem Cell Deficiency (LSCD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Limbal Stem Cell Deficiency (LSCD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Augustine Grp/ BrightStar Corp/ Fortress Real – The South Shore Mixed-Use Development – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our Augustine Grp/ BrightStar Corp/ Fortress Real - The South Shore Mixed-Use Development - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Analyst Opinions
4G Commercial Strategies in Africa and the Middle East
In the MENA region, operators are increasingly developing online stores and marketing OTT services through OTT partnerships to increase 4G-compatible smartphones and increase data bundle adoption. In sub-Saharan Africa, operators largely rely on informal distribution networks to reach their addressable market and offer promotional data bundles for specific services (e.g., social network data bundles), this will support 4G uptake over the next five years. In the battle for market share, the success of an operator to acquire 4G subscriptions in...